Press Releases about PfizerFrom Pfizer Inc.
Via Business Wire
Via MarketBeat
Topics
Artificial Intelligence
Via MarketBeat
Topics
Initial Public Offering
Pfizer’s Elranatamab Receives FDA and EMA Filing Acceptance
February 22, 2023
From Pfizer Inc.
Via Business Wire
Via SBWire
FDA Approves Pfizer's Supplemental New Drug Application for CIBINQO® (abrocitinib)
February 10, 2023
From Pfizer Inc.
Via Business Wire
Europe Liver Cancer Therapeutics Market to Reach at High CAGR of 8.95% by 2023-2030
February 09, 2023
Via SBWire
Pfizer Invites Public to Listen to Webcast of Pfizer Discussion at Healthcare Conference
February 09, 2023
From Pfizer Inc.
Via Business Wire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|